Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill ...

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...

Kym Whitley partners with Eli Lilly to share her transformative experience using Zepbound, an obesity management medication.

The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, ...

Stocks are drifting in mixed trading on Wall Street after President Donald Trump’s latest tariffs took effect on dozens of ...

Trump hasn’t made Supreme Court appointments yet this term. But his three first-term picks — Neil Gorsuch, Brett Kavanaugh and Amy Coney Barrett — continue to deliver for the Christian conservatives ...

Fortinet, AppLovin, Airbnb, Duolingo and more stock were making big moves Thursday after the companies reported quarterly ...

Eli Lilly’s new weight-loss daily pill underperformed against competitors in weight... The Competition and Consumer ...